Carlo Capalbo Selected Research

Carlo Capalbo Research Topics

Disease

17	Neoplasms (Cancer) 01/2022 - 01/2014
4	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 07/2014
3	Breast Neoplasms (Breast Cancer) 01/2024 - 08/2020
3	COVID-19 10/2022 - 10/2021
3	Carcinogenesis 08/2017 - 02/2014
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 03/2019
2	Medulloblastoma 11/2020 - 01/2019
1	Rectal Neoplasms (Rectal Cancer) 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Critical Illness (Critically Ill) 12/2021
1	Infections 10/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Pathologic Processes 08/2020
1	Ovarian Neoplasms (Ovarian Cancer) 01/2019
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2018
1	Triple Negative Breast Neoplasms 05/2018
1	Inflammation (Inflammations) 01/2018
1	Neuroblastoma 01/2018
1	Liver Neoplasms (Liver Cancer) 08/2017
1	Liver Diseases (Liver Disease) 08/2017
1	Non-alcoholic Fatty Liver Disease 08/2017
1	Pancreatic Neoplasms (Pancreatic Cancer) 08/2015
1	Glioma (Gliomas) 01/2014

Drug/Important Bio-Agent (IBA)

3	MicroRNAs (MicroRNA)IBA 08/2020 - 01/2014
2	Thyroid HormonesIBA 10/2022 - 12/2021
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2022 - 02/2017
2	AntioxidantsIBA 10/2022 - 01/2020
2	pembrolizumabIBA 01/2021 - 03/2019
2	Transcription Factors (Transcription Factor)IBA 01/2019 - 01/2018
2	HhAntag691IBA 01/2019 - 01/2017
1	Immunoconjugates (Immunoconjugate)IBA 01/2024
1	Oxygen (Dioxygen)IBA 10/2022
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 10/2022
1	Fluorouracil (Carac)FDA LinkGeneric 01/2022
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022
1	SaltsIBA 12/2021
1	PotassiumIBA 12/2021
1	Messenger RNA (mRNA)IBA 12/2021
1	SodiumIBA 12/2021
1	CytokinesIBA 10/2021
1	InterferonsIBA 10/2021
1	DNA (Deoxyribonucleic Acid)IBA 12/2020
1	Phenformin (Fenformin)IBA 11/2020
1	Hypoglycemic Agents (Hypoglycemics)IBA 11/2020
1	BiguanidesIBA 11/2020
1	Therapeutic UsesIBA 11/2020
1	Co-Repressor ProteinsIBA 11/2020
1	Biomarkers (Surrogate Marker)IBA 08/2020
1	Untranslated RNA (Noncoding RNA)IBA 08/2020
1	LigandsIBA 11/2019
1	Galectins (Galectin)IBA 03/2019
1	Galectin 3 (LGALS3)IBA 03/2019
1	B7-H1 AntigenIBA 03/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	NucleotidesIBA 01/2019
1	NocodazoleIBA 01/2019
1	MitogensIBA 01/2019
1	PlatinumIBA 07/2018
1	Tyrosine (L-Tyrosine)FDA Link 05/2018
1	Gefitinib (Iressa)FDA Link 05/2018
1	6- (4- hydroxyphenyl)- 2- thioxo- 2,3- dihydro- 4(1H)- pyrimidinoneIBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 08/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2017
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 08/2017
1	CarbohydratesIBA 08/2017
1	PeroxiredoxinsIBA 02/2017
1	Oxidants (Oxidizing Agents)IBA 02/2017
1	mocetinostatIBA 01/2017
1	ParaffinIBA 09/2015
1	Formaldehyde (Formol)FDA Link 09/2015
1	Calcibiotic Root Canal SealerIBA 09/2015
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 08/2015
1	Panitumumab (Vectibix)FDA Link 07/2014
1	VemurafenibIBA 07/2014
1	Tumor Biomarkers (Tumor Markers)IBA 02/2014

Therapy/Procedure

5	Therapeutics 01/2022 - 07/2014
2	Immunotherapy 01/2021 - 03/2019
1	Drug Therapy (Chemotherapy) 01/2022
1	Radiotherapy 01/2020
1	Ligation 01/2019